Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03088345 · ClinicalTrials.gov registry record · Phase 2
Early Use of Vasopressin in Post-Fontan Management
A Phase 2 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT03088345 is a Phase 2 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 20 participants.
The verdict
NCT03088345, a Phase 2 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is an investigator initiated, prospective, single-center, double-blinded, randomized, placebo-controlled trial of post-operative low dose vasopressin infusions as an early treatment of low systemic perfusion in pediatric patients following Fontan palliation.
Interventions
- DRUG Placebo
- DRUG Vasopressin, Arginine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-03-06 |
| Est. Completion | 2019-01-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03088345
The ClinicalTrials.gov registry entry for NCT03088345 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03088345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03088345 about?
NCT03088345 is a clinical study titled "Early Use of Vasopressin in Post-Fontan Management". This is an investigator initiated, prospective, single-center, double-blinded, randomized, placebo-controlled trial of post-operative low dose vasopressin infusions as an early treatment of low systemic perfusion in pediatric patients following Fontan palliation.
What is the current status of trial NCT03088345?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2017-03-06. Estimated completion is 2019-01-28.
What interventions are being tested in trial NCT03088345?
The interventions under investigation include: Placebo (DRUG), Vasopressin, Arginine (DRUG).
Who is sponsoring clinical trial NCT03088345?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.